Evidence map›Paper›PMID 39092438›Full record

ArticleRSC chemical biology2024

Seleno-relaxin analogues: effect of internal and external diselenide bonds on the foldability and a fibrosis-related factor of endometriotic stromal cells.

Yuri Satoh, Yosuke Ono, Rikana Takahashi, Hidekazu Katayama, Michio Iwaoka, Osamu Yoshino, Kenta Arai

Abstract read
In one paragraph

Article in RSC chemical biology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Effects of Selenocysteine Substitution on the Cyclotide Kalata B2.Chembiochem : a European journal of chemical biology · 2026
    Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Yuri SatohDepartment of Chemistry, School of Science, Tokai University Kitakaname Hiratsuka-shi Kanagawa 259-1292 Japan k-arai4470@tokai-u.jp +81-463-50-2094 +81-463-58-1211.
Yosuke OnoDepartment of Obstetrics and Gynecology, University of Yamanashi 1110 Shimokato Chuo-shi Yamanashi 409-3898 Japan.
Rikana TakahashiDepartment of Chemistry, School of Science, Tokai University Kitakaname Hiratsuka-shi Kanagawa 259-1292 Japan k-arai4470@tokai-u.jp +81-463-50-2094 +81-463-58-1211.
Hidekazu KatayamaDepartment of Bioengineering, School of Engineering, Tokai University Kitakaname Hiratsuka-shi Kanagawa 259-1292 Japan.
Michio IwaokaDepartment of Chemistry, School of Science, Tokai University Kitakaname Hiratsuka-shi Kanagawa 259-1292 Japan k-arai4470@tokai-u.jp +81-463-50-2094 +81-463-58-1211.ORCID https://orcid.org/0000-0002-6271-0185
Osamu YoshinoDepartment of Obstetrics and Gynecology, University of Yamanashi 1110 Shimokato Chuo-shi Yamanashi 409-3898 Japan.
Kenta AraiDepartment of Chemistry, School of Science, Tokai University Kitakaname Hiratsuka-shi Kanagawa 259-1292 Japan k-arai4470@tokai-u.jp +81-463-50-2094 +81-463-58-1211.ORCID https://orcid.org/0000-0003-0785-2559

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Human relaxin-2 (H2 relaxin) is a peptide hormone of about 6 kDa, first identified as a reproductive hormone involved in vasoregulation during pregnancy. It has recently attracted strong interest because of its diverse functions, including anti-inflammatory, anti-fibrotic, and vasodilatory, and has been suggested as a potential peptide-based drug candidate for a variety of diseases. Mature H2 relaxin is constituted by the A- and B-chains stabilized by two interchain disulfide (SS) bridges and one intrachain SS linkage. In this study, seleno-relaxins, SeRlx-α and SeRlx-β, which are [C11U

Identifiers

PMID39092438
PMCPMC11289879

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.